Maureen K OConnor
Overview
Explore the profile of Maureen K OConnor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
OConnor M, Frank B, DeCaro R, Vives-Rodriguez A, Hurley L, Turk K, et al.
Int J Geriatr Psychiatry
. 2024 Oct;
39(10):e70002.
PMID: 39434195
Objective: To investigate the association between suspected pseudobulbar affect (PBA), clinical diagnosis, cognitive testing, and self-reported mood in older adults presenting for evaluation of dementia. Participants: Patients presenting to an...
3.
Bell Z, OConnor M, Moo L
J Am Geriatr Soc
. 2024 Oct;
73(2):349-357.
PMID: 39387518
Dementia is a syndrome characterized by cognitive changes which interfere with daily functioning. Neuropsychiatric symptoms (NPS) are also pervasive and may even occur prior to any noticeable cognitive decline. Still,...
4.
Frank B, Walsh M, Hurley L, Groh J, Blennow K, Zetterberg H, et al.
J Alzheimers Dis
. 2024 Jul;
100(3):1055-1073.
PMID: 38995786
Background: Neuropsychiatric symptoms (NPS) can be an early manifestation of Alzheimer's disease (AD). However, the associations among NPS, cognition, and AD biomarkers across the disease spectrum are unclear. Objective: We...
5.
Aguilar B, Jasuja G, Li X, Shishova E, Palacios N, Berlowitz D, et al.
J Alzheimers Dis
. 2024 May;
99(3):1065-1075.
PMID: 38788073
Background: Diagnostic codes can be instrumental for case identification in Alzheimer's disease (AD) research; however, this method has known limitations and cannot distinguish between disease stages. Clinical notes may offer...
6.
OConnor M, Aguilar B, Nguyen A, Berlowitz D, Zhang R, Monfared A, et al.
Mil Med
. 2024 Apr;
189(7-8):1409-1413.
PMID: 38668648
Introduction: The benefits of early detection of Alzheimer's disease (AD) have become increasingly recognized. Veterans with mental health conditions (MHCs) may be less likely to receive a specific AD diagnosis...
7.
Frank B, Bandyopadhyay S, Dion C, Formanski E, Matusz E, Penney D, et al.
Assessment
. 2024 Mar;
32(1):119-129.
PMID: 38494894
Graphomotor and time-based variables from the digital Clock Drawing Test (dCDT) characterize cognitive functions. However, no prior publications have quantified the strength of the associations between digital clock variables as...
8.
Rindge M, Strainge L, OConnor M
BMC Med Educ
. 2024 Jan;
24(1):40.
PMID: 38191384
Memory clinics that specialize in evaluating and treating cognitive decline in older adults are increasingly common and serve as an important training setting for neuropsychology practicum students, interns, and postdoctoral...
9.
Gately M, Metcalf E, Waller D, McLaren J, Chamberlin E, Hawley C, et al.
Top Geriatr Rehabil
. 2023 Oct;
39(4):253-265.
PMID: 37901356
Caregiver involvement may facilitate patient participation in occupational therapy (OT) video telehealth. However, little is known about the extent to which caregivers participate and what they do. This scoping review...
10.
Ally M, Sugarman M, Zetterberg H, Blennow K, Ashton N, Karikari T, et al.
Alzheimers Dement (Amst)
. 2023 Oct;
15(4):e12492.
PMID: 37885919
Introduction: This study examined plasma glial fibrillary acidic protein (GFAP) as a biomarker of cognitive impairment due to Alzheimer's disease (AD) with and against plasma neurofilament light chain (NfL), and...